Background/Aims: The E3 ubiquitin ligase ITCH plays an important role in invasive and metastatic cancers. However, the role of ITCH in the progression of lung cancer has not been fully described. Methods: Real-time PCR was used to detect the expression of ITCH mRNA in the tumor tissues and paracarcinoma tissues from 32 patients with lung cancer. SiRNA was used to inhibit the expression of ITCH in two lung cancer cell lines, H1975 and Calu3 and the cell proliferation and apoptosis were measured by MTT and flow cytometric assay. In addition, to further investigate whether ITCH affected the apoptosis of cancer cells and its underlying mechanisms, the expression of important markers of apoptosis and invasion in lung cancer cells were detected by Western blot. Results: The study showed significant increments in the expression of ITCH in lung cancer tissues (p<0.001). ITCH siRNA effectively inhibited the proliferation and invasion of the lung cancer cells and promoted cell apoptosis. Molecular analysis further showed significant reductions in the expression of Bcl2, MMP2, MMP9 and β-catenin and an increase in the expression of Bax and E-cadherin in the lung cancer cells with ITCH deficiency. Conclusions: Inhibition of ITCH might suppress lung cancer proliferation and invasion via regulation of MMPs, EMT and Bcl2/Bax signaling pathway.
Introduction
Lung cancer is the most common malignant cancer and a leading cause of mortality in China. Advanced lung cancer has a high tendency for metastasis. Despite constant progress in chemotherapy and surgery, the overall five-year survival rate of advanced lung cancer is less than 15%. Tumor metastasis contributes to over 90% of cancer mortality [1] . Therefore, identifying novel therapeutic targets are important not only for the current therapy strategies but also for further understanding of the underlying molecular mechanism for these metastatic cancers.
The Ubiquitin Proteasome Pathway is the principal mechanism for protein catabolism in the mammalian cytosol and nucleus. The highly regulated Ubiquitin affects a wide variety of cellular processes, substrates, and defects in the system, resulting in the pathogenesis of several important human cancers [2] . E3 ubiquitin ligases are final effectors of the enzyme which has the highest level of substrate specificity for the conjugation cascade controlling ubiquitylation. A central issue in understanding their regulation is to decipher mechanisms of their assembly and activity [3] .
ITCH, a HECT class E3 ubiquitin ligase, is recognized as a unique binding partner of large tumor suppressor (LATS1) [4] . ITCH can form a complex with LATS1 both in vitro and in vivo through the PPxY motifs of LATS1 and the WW domains of ITCH [5] . Knockdown of endogenous ITCH by shRNAs provokes stabilization of endogenous LATS1 proteins. In addition, through several functional assays, a positive correlation between ITCH and tumor progression has been reported in breast cancer, prostate cancer, hepatocellular carcinoma, and chronic lymphocytic leukemia [6] [7] [8] . However, the role of ITCH in the progression of lung cancer has not been fully described.
In this study, we detected the expression of ITCH in tumor tissues and paracarcinoma tissues from 32 patients with lung cancer by real-time PCR. Next, we inhibited the expression of ITCH using ITCH siRNA and measured its effects in cell proliferation and invasion of two lung cancer cell lines (H1975 and Calu3). We further investigated whether ITCH affected the apoptosis of cancer cells and its underlying mechanisms.
Materials and Methods

Patients and tissue samples
Tumor tissues and paracarcinoma tissues from 32 patients with lung cancer were obtained at the Department of Thoracic Surgery in Liaoning Provincial Cancer Hospital (Shenyang, China) between 2012 and 2013. The paracarcinoma tissues were resected within 5 cm from the tumor margin. All patients were subsequently treated by radical mastectomy therapy for lung cancer. This study was approved by the institutional Research Ethics Board in Liaoning Provincial Cancer Hospital (Shenyang, China).
Cell culture
The following lung cancer cell lines: H1975, A549, Calu3, and SK-LU-1cells were cultured in low glucose DMEM mediums (GIBCO BRL, Germany), supplemented with 10% fetal bovine serum (GIBCO BRL, Germany), 4 mmol/L L-glutamine, 100 units/mL penicillin, and 100 μg/mL streptomycin, and incubated at 37°C in an atmosphere with 5% CO 2 .
Silencing of ITCH by siRNA
The siRNA plasmid that contains a green fluorescent protein gene for tracking the transfection efficiency, was synthesized by GeneChem Ltd (Shanghai, China). The target sequence is 5'-TTGCATACTCCGACAGGCT-3', corresponding to the ITCH mRNA. The sense sequence of siNC (negative control) is 5'-UUCUCCGAACGUGUCAGGUTT-3'. Cell lines including H1975, A549, Calu3 and SK-LU-1cells were transiently transfected with siRNA complexes that combine the lipofectamine 2000 reagent and induced by 1 mg/ml tetracyclines for 48 h following the manufacturer's protocol (Invitrogen CA, USA). All the assays were performed 24 h after transfection.
Cell proliferation assay
Briefly, cells were treated with various siRNA and 48 h later, cell viability was measured by MTT to determine the combined cytotoxic effect. In brief, after cells were treated with different siRNAs, MTT solution was added to the cultured cells to a final concentration of 0.1 mg/ml and incubated at 37 °C for 4 h. The culture medium was then discarded and dimethyl sulfoxide (DMSO) was added into the medium and was shaken at room temperature for 10 minutes. The Absorbance was measured with an enzyme immunoassay instrument (GeneChem, Shanghai, China) at 570 nm that serves as a measure of cell viability. 
Flow cytometric assay of cell apoptosis
Real-time PCR
Total RNA was isolated from lung cancer cells using Trizol reagent by following the manufacturer's protocol and subsequently reverse transcribed with reverse transcriptase and random primers (Invitrogen CA, USA) to synthesize the first strand of cDNA. Quantitative real-time PCRs were then implemented on an Exicycler TM 96 thermal block (Bioneer, Daejeon, Korea) with SYBR Green PCR master mix (Tiangen Biotech, Shanghai, China). PCRs were prepared in duplicate, and cycling program was set at initial hold at 95℃ for 15 min followed by 40 cycles of denaturation at 95℃ for 10 s, annealing at 60 ℃ for 20 s, and extension at 72℃ for 30 s. The primers used were listed as follows: ITCH, 5'-GAAGGCACGAATGGAATAG-3' and 5'-GTGACAGACGCATTATCAG-3'; GAPDH, 5'-CACCCACTCCTCCACCTTTG-3' and 5'-CCACCACCCTGTTGCTGTAG-3'). The specificity of each PCR was verified by melting curve analysis. Relative mRNA expression levels were calculated using the threshold cycle (Ct) method.
Western blotting
Cells were harvested 3 days post-transfection and lysed in buffer containing protease inhibitors (50 mmol/L Hepes, pH 7.4, 250 mmol/L NaCl, 1 mmol/L DTT, 1 mmol/L EDTA,1 mmol/L NaF, and 1% Triton X-100). Total protein (30-50 μg) was separated on SDS-polyacrylamide gels under reducing conditions, transferred to polyvinylidene fluoride membranes (Millipore), and detected by the following antisera: antibodies of E-cadherin, β-catenin and GAPDH at 1:1000 (Cell Signaling Technology, Danvers, MA, USA); antibodies of ITCH, MMP2 and MMP9 at 1:1000 (Alung cancerm, Cambridge, MA, USA); antibodies of Bcl2 and Bax at 1:500 (Santa Cruz, CA, USA). The detection was by horseradish peroxidase-conjugated secondary IgG-antibodies (Santa Cruz, CA, USA). Chemiluminescence reagent (Tiangen Biotech, Shanghai, China) was followed by autoradiography (BioMaxfilm, Kodak).
Statistical analysis
All data are presented as mean± standard deviation [SD] . Comparisons between two groups were performed with the Student's t test. P-value < 0.05 (two-tailed) was considered statistically significant. All analyses were performed using the SPSS software (version 13.00, SPSS Inc., IL, USA).
Results
Increased expression of ITCH in human lung cancer tissues
As shown in Fig. 1A , the mRNA expression of ITCH was significantly increased in the cancer tissues compared with that in the paracarcinoma tissues (4.88±0.23 vs. 1.93±0.28, n=26, mean ratio of 2.44-fold, P<0.001). The log2 ratio of tumor vs. paracarcinoma for ITCH was further calculated. Positive log2 indicated the increased expression of ITCH, which was observed in 80.7% (21/26) of tested lung cancer tissues (Fig. 1B) . Fig. 2B and 2C show the expressions The results showed that both mRNA and protein levels of ITCH were higher in H1975 and Calu3 cell lines than those in A549 and SK-LU-1 cell lines. Therefore, we chose the H1975 and Calu3 lung cancer cell lines in the following experiments. In order to determine the effects of ITCH in lung cancer, we used the ITCH siRNA to decrease the expression of ITCH. As shown in Fig. 2A , the transfection efficiency of the siRNA was detected with the expression of green fluorescence in H1975 cell line. Western blot showed that the protein expression of ITCH was dramatically inhibited both in the H1975 and in Calu3 cell lines as compared to the control siRNA ( Fig. 2D and 2E) . (Fig.  3B) . As shown in Fig. 3B , the percentage of apoptotic cells was 2.1% and 1.9% in the H1975 cells and Calu3 cells separately. Meanwhile, the apoptotic rates in the siRNA control groups were 
Silencing of ITCH in lung cancer cells by siRNA
Silencing
ITCH deficiency regulated apoptosis and invasion-related factors
To further explore the underlying mechanism of ITCH in invasion and apoptosis, the expression of important markers of apoptosis and invasion were estimated at the protein level in lung cancer cells by Western blot (Fig. 4) . The results showed that siITCH significantly reduced the expression of Bcl2 (p < 0.01) and increased the expression of Bax (p < 0.05), suggesting that siITCH may contribute the induction of lung cell apoptosis via Bcl2/Bax signaling pathway. Moreover, the protein levels of the invasive regulators including MMP2 (2.73 ± 0.27 folds, p < 0.001), MMP9 (2.58 ± 0.22 folds, p < 0.05) and β-catenin (1.81 ± 0.31 folds, p < 0.05) were significantly down regulated in the siITCH group compared with those in the siRNA control group. In addition, the anti-invasion molecule E-cadherin was remarkably increased in the siITCH group. In summary, our results demonstrated that ITCH contribute to the proliferation, invasion and apoptosis of lung cancer cells, and targeting ITCH may have therapeutic potential in the treatment of lung cancer.
Discussion
In the present study, we investigated multiple effects of siITCH on lung cancer cells viability, invasion and apoptosis and the underlying mechanism by which siITCH exerted its anti-tumor effects. Our results showed that siITCH decreased cell viability, invasion and promote lung cancer cell apoptosis. More importantly, siITCH reduced the expression of Bcl2 and increased the expression of Bax, indicating that siITCH induces cell apoptosis via regulating Bcl2/Bax signaling pathway. In addition, siITCH reduced the expression of invasive regulators including MMP2, MMP9 and β-catenin. However, the anti-invasion molecule E-cadherin was increased when ITCH deficiency. Our results demonstrated that ITCH may have therapeutic potential in the treatment of lung cancer.
Lung cancer has been the leading cause of cancer-related mortality worldwide in recent years [9] . However, this disease metastasizes early and surgical intervention is rarely a therapeutic option [10] . The metastasis of lung cancer involves many biological processes; local invasion is one of the most important step and major cause of death in patients with [11, 12] . Our results further showed that silencing of ITCH could inhibit the migration and invasion of lung cancer cells via regulating matrix metalloproteinase (MMPs), including MMP2 and MMP9, indicating that siITCH effectively inhibits the invasion of lung cancer cells. Studies reported that epithelial mesenchymal transition (EMT) plays a critical role in cancer processing and metastasis [13] . Our results showed that knockdown of ITCH could reverse EMT markers (β-cadherin and E-cadherin) in the two lung cancer cells, suggesting that ITCH may promote tumor cell infiltration by inducing EMT. Further investigations are required to clarify the underlying mechanism of this progress.
ITCH is an E3-ubiquitin ligase that regulates the ubiquitination of several targets and participating in the regulation of several cellular responses, including the TNFα, Notch and Hedgehog signaling and DNA damage response [2, 14] . A wide range of studies reported that the expression of ITCH is up regulated in various tumor tissues [14] . Recent study showed that ITCH plays a negative regulatory role in the progression of breast cancer and colorectal cancer, mainly by regulating the Wnt/β-catenin pathway [15] . Consistent with previous study, our results showed that silencing the ITCH effectively inhibited the proliferation of lung cancer cells. Meanwhile, siITCH also dramatically promoted the apoptosis of lung cancer cells via regulating Bcl2/Bax signaling pathway, indicating that siITCH plays an antiapoptotic role in lung cancer cells.
In conclusion, our study demonstrates that inhibition of ITCH may suppress the lung cancer cells proliferation, invasion and promote cells apoptosis. These anti-tumor characters of siITCH were achieved by regulating several molecules and singling pathway, including MMPs, EMT and Bcl2/Bax. Further characterization of the function of ITCH in cancer progression will have great implications on the development of cancer diagnosis and therapy.
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